| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |